AI assistant
Sending…
AGENUS INC — Director's Dealing 2010
May 17, 2010
34023_dirs_2010-05-17_1342b442-5f2c-4f1c-99a9-56729ef38607.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-05-13
Reporting Person: Corvese Brian (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-05-13 | Stock Option (right to buy) | $1.24 | A | 15000 | Acquired | 2020-05-13 | Common Stock (15000) | Direct |
Footnotes
F1: Options vest in three equal annual installments beginning May 13, 2011.
More from AGENUS INC
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 9
Director's Dealing
2026
Jan 26
Major Shareholding Notification
2026
Jan 23